(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with Memory Disorders in 1 studies
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride: A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
Excerpt | Relevance | Reference |
---|---|---|
"Memory deficits are induced during the late stage (20-25 days) of thiamine-deficient (TD) feeding." | 2.43 | Behavioral and neurochemical alterations following thiamine deficiency in rodents: relationship to functions of cholinergic neurons. ( Nakagawasai, O, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakagawasai, O | 1 |
1 review available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Memory Disorders
Article | Year |
---|---|
Behavioral and neurochemical alterations following thiamine deficiency in rodents: relationship to functions of cholinergic neurons.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Behavior, Animal; Bra | 2005 |